Skip to main content
. 2015 Feb 19;10(2):e0115189. doi: 10.1371/journal.pone.0115189

Fig 1. TRAMPMIC-/- mice have shorter survival and larger prostate tumors than TRAMPMIC+/+ mice.

Fig 1

(A) Survival data for TRAMPMIC+/+ and TRAMPMIC-/- mice (n = 35). Overall survival of individual mice from birth to death was plotted using the Kaplan-Meier method. The log-rank statistic for median survival time is shown. (B) The genitourinary complex (GU) and prostate tumor weights (C), in TRAMPMIC+/+ and TRAMPMIC-/- mice, at the necropsy, are corrected for body weight and presented as mean ± SEM. Differences are analyzed using an unpaired 2-tailed t test. (D) The number of TRAMPMIC+/+ and TRAMPMIC-/- mice having large prostate tumor (corrected tumor wt>10mg/g), was compared using a Chi-square test. p values are shown as *, p< 0.05; **, p< 0.01.